Sentinel node in ovarian cancer

Completed

• Conditions: malignancy of the ovary; ovarian cancer; 10038594

• Registration Number: NL-OMON37538
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 28

Inclusion Criteria

The following patients will be included:
Cohort 1: patients with a high suspicion of an ovarian malignancy in whom a median laparotomy and a frozen section analysis is planned.
Cohort 2: patients with endometrial cancer in whom a staging laparotomy is planned.

Exclusion Criteria

- Previous surgery of the ovaries.
- Previous vascular surgery of the aorta, caval vein, and/or iliac vessels
- Previous lymphadenectomy of lymph node sampling in the iliac or para-aortal region.
- History of a malignant lymphoma
- History of a malignant tumour in the abdominal cavity.
- Previous allergic reaction to blue dye.
- Pregnant or lactating patients

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Percentage of patients in whom sentinel node(s) will be identified. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Location of the sentinel node(s)<br /><br>- Incidence of false negative nodes.</p><br>